NCT01380457View on ClinicalTrials.gov

Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

69

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

April 30, 2006

Study Completion Date

April 30, 2006

Conditions
To Determine Bioequivalence Under Fasting Conditions
Interventions
DRUG

Dronabinol

Capsules, 10 mg, single dose, fasting conditions

DRUG

Marinol

Capsules, 10 mg, single-dose, fasting conditions

Trial Locations (1)

21201

BASi, Baltimore

Sponsors
All Listed Sponsors
collaborator

BASi Clinical Research Unit

UNKNOWN

lead

Par Pharmaceutical, Inc.

INDUSTRY